Chohan, Muhammad O.
Fein, Halli
Mirro, Sarah
O’Reilly, Kally C.
Veenstra-VanderWeele, Jeremy
Funding for this research was provided by:
National Institutes of Health (MH114296)
Article History
Received: 12 May 2023
Accepted: 2 August 2023
First Online: 18 August 2023
Declarations
:
: JV has served on advisory boards for Roche, Novartis, and SynapDx; has received research funding from NIH, Simon’s Foundation, Roche, Novartis, SynapDx, Forest, Janssen, Yamo, MapLight, Seaside Therapeutics, and Acadia Pharmaceuticals; and has received editorial stipends from Wiley and Springer. The remaining authors declare no competing interests.